Bath & Body Works (BBWI) Projected to Post Earnings on Thursday

Bath & Body Works (NYSE:BBWI) is projected to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Bath & Body Works to post earnings of $2.04 per share and revenue of $2.78 billion for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same period in the previous year, the business earned $0.48 earnings per share. The company’s revenue was up 3.1% on a year-over-year basis. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Stock Up 3.6 %

Shares of NYSE BBWI opened at $39.99 on Tuesday. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm’s 50-day simple moving average is $37.73 and its 200 day simple moving average is $33.96. The stock has a market cap of $8.66 billion, a P/E ratio of 9.75, a P/E/G ratio of 0.92 and a beta of 1.83.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works’s dividend payout ratio is currently 19.51%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Morgan Stanley dropped their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research note on Thursday, November 21st. TD Cowen lifted their target price on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $42.00 to $48.00 in a report on Friday, January 10th. Six analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $44.19.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.